MTNB
MTNB clinical trials: Matinas BioPharma Holdings, Inc.
Every trial on ClinicalTrials.gov where Matinas BioPharma Holdings, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 2
- As lead sponsor
- 2
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
MTNB on the catalyst calendar · MTNB registry changes
- Primary completion Aug 2022Sponsor estimatePhase 3NCT04662528Safety and Efficacy of MAT9001(Omega-3-pentaenoic Acid) in Subjects With Triglycerides ≥500 mg/dL and <2000 mg/dLMatinas Biopharma, Inc · Severe HypertriglyceridemiaWithdrawnMTNBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2015ActualPhase 1/Phase 2NCT02310022A PK and PD Study of Two Formulations of Omega-3 One Gram CapsulesMatinas Biopharma, Inc · HypertriglyceridemiaCompletedMTNBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimateNo phase registeredNCT01731353FungiScope - A Global Emerging Fungal Infection RegistryUniversity of Cologne · Invasive Fungal Disease
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 27, 2020ActualPhase 2NCT04177680Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With HypertriglyceridemiaMatinas BioPharma Nanotechnologies, Inc. · HypertriglyceridemiaCompletedMTNBCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner